Brilaroxazine

Brilaroxazine (RP5063) is a multimodal dopamine and serotonin modulator, acting as a partial agonist at D2, D3, D4, 5-HT1A, and 5-HT2A receptors and an antagonist at 5-HT2B and 5-HT7 receptors. Its pharmacological profile supports research into cognitive deficits associated with schizophrenia and Parkinson's disease, as evidenced in preclinical in vivo models.

Product Specifications

CAS Number

1239729-06-6

Product Name Alternative

Syndrome, ADHD, RP5063, RP-5063, RP 5063, Pulmonary, Serotonin Receptor, 5-HT7 Receptor, 5-HT7, 5HT Receptor, 5-hydroxytryptamine Receptor, 5HTReceptor, Alzheimer, 5-HT1A Receptor, 5-HT2B Receptor, 5-HT2A Receptor, 5-HT2B, 5-HT2A, 5-HT1A, 5-HT Receptor, autism, arterial, cardiac, DopamineReceptor, Dopamine Receptor, disorder, Tourette, depressive, D4 receptor, D4 Receptor, D2 receptor, D2 Receptor, D3 Receptor, D3 receptor, Brilaroxazine, Inhibitor, hypertension, inhibit, PAH, Parkinson